01
Normal for this patient looks abnormal to the model
Enlarged hearts, thickened skull bones, missing spleens, and bone marrow expansion are routine in this population. A general model flags them as findings and buries the real one in false alarms.
What we do. The model is evolved on confirmed cases from the cohort, so the baseline anatomy of the disease is learned as the baseline, not as pathology.
02
The findings that kill are subtle and fast
Acute chest syndrome begins as a faint new infiltrate on a chest X-ray that already looks busy. The hours between the first film and the diagnosis are where outcomes are decided.
What we do. Recall on early acute chest syndrome is a hard floor in the evolution loop. A candidate that misses it is discarded before anything else is scored.
03
Half the patients are children
Pediatric imaging has its own anatomy, its own protocols, and far less training data. Most imaging AI was validated on adults and says so in the fine print.
What we do. Performance on the pediatric subgroup is a separate objective. The model cannot win on adults by losing on children.
04
No one builds for a market this specific
A product aimed at the global average has no reason to spend a year on one region's disease. So the region's hospitals get the global average.
What we do. We do not build a new product for each cohort. We evolve our existing systems to it, which is a matter of weeks of search, not years of development.